0.80
-0.0296(-3.57%)
Currency In USD
| Previous Close | 0.83 |
| Open | 0.82 |
| Day High | 0.82 |
| Day Low | 0.75 |
| 52-Week High | 6.65 |
| 52-Week Low | 0.31 |
| Volume | 1.34M |
| Average Volume | 7.72M |
| Market Cap | 22.33M |
| PE | -0.43 |
| EPS | -1.85 |
| Moving Average 50 Days | 0.74 |
| Moving Average 200 Days | 1.55 |
| Change | -0.03 |
If you invested $1000 in SeaStar Medical Holding Corporation (ICU) since IPO date, it would be worth $1.28M as of August 20, 2025 at a share price of $0.8. Whereas If you bought $1000 worth of SeaStar Medical Holding Corporation (ICU) shares 3 years ago, it would be worth $48,923.68 as of August 20, 2025 at a share price of $0.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025
GlobeNewswire Inc.
Aug 07, 2025 2:00 PM GMT
DENVER, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, annou
SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)
GlobeNewswire Inc.
Aug 06, 2025 12:33 PM GMT
Trial now over 60% enrolled with 125 of 200 anticipated patients Recent new site activation brings total clinical trial sites to 16 Interim analysis of first 100 patients remains on track for 3Q 2025 DENVER, Aug. 06, 2025 (GLOBE NEWSWIRE) -- SeaSta
SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Jul 31, 2025 7:01 PM GMT
DENVER, July 31, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today